Search Result for:
Canakinumab First FDA-Approved Therapy for Adult-Onset Still's Disease
Yesterday, the FDA approved canakinumab (Ilaris) as treatment for adult-onset Still’s disease (AOSD), the…
View Resource
TNR Grand Rounds – Cytokine Storm Syndromes
This week’s Tuesday Nite Rheumatology featured Dr Randy Cron from the University of Alabama –…
View Resource
Earlier Anakinra Initiation Warranted in Still's Disease
An Italian study examined the outcomes in adult onset Still’s disease (AOSD) based on…
View Resource